Login / Signup

Effect of SGLT2 inhibitors on cardiovascular events in patients with atrial fibrillation: A systematic review and meta-analysis of randomized controlled trials.

Shiyue ZhengYi-Wei LaiChao JiangLiu HeZixu ZhaoWenjie LiRi-Bo TangCai-Hua SangDe-Yong LongXin DuChang-Sheng MaJianzeng Dong
Published in: Pacing and clinical electrophysiology : PACE (2023)
The treatment effects of SGLT2i were associated with a lower incidence of CV events, especially HF hospitalization, in patients with AF.
Keyphrases
  • cardiovascular events
  • coronary artery disease
  • cardiovascular disease
  • risk factors
  • atrial fibrillation
  • type diabetes
  • heart failure
  • acute heart failure
  • replacement therapy